| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CEO And President | See Remarks
1 company
Kumar Neil is a Chief Executive Officer at BridgeBio Pharma, Inc.. Recent SEC Form 4 filings include 0 buys and 26 sells.
Estimated insider holdings value: $40.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2020 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 80,000 | $27.23 | $2,178,066.07 | -0.9% | |
| Jul 2, 2020 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 143,470 | $30.75 | $4,411,357.06 | -1.6% | |
| Jun 8, 2020 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 10,600 | $30.01 | $318,125.08 | -0.5% | |
| Jun 3, 2020 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 5,930 | $30.05 | $178,173.37 | -0.3% | |
| Jun 1, 2020 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 80,000 | $29.19 | $2,335,389.61 | -1.7% | |
| May 5, 2020 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 79,600 | $31.02 | $2,469,481.93 | -1.6% | |
| May 4, 2020 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 80,400 | $29.40 | $2,364,085.00 | -0.8% | |
| Apr 7, 2020 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 1,805 | $25.48 | $45,983.10 | - | |
| Apr 3, 2020 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 300 | $25.09 | $7,528.00 | - | |
| Apr 2, 2020 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 77,895 | $26.02 | $2,026,465.64 | -0.6% |